ResearcherNo recent work listed

Wei Lv

Provisional: name only (low confidence, 0.40), identity_conf@1As of 7 November 2026

Known by name only; no external author ID or institution yet. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2017: 1 paper

Papers 1

Astaxanthin inhibits gemcitabine-resistant human pancreatic cancer progression through EMT inhibition and gemcitabine resensitization. Last author DOI 10.3892/ol.2017.6836 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Weihong Duan · 1 shared paper, 2017 · strength 0.07
- Paper Astaxanthin inhibits gemcitabine-resistant human pancreatic cancer progression through EMT inhibition and gemcitabine r… DOI 10.3892/ol.2017.6836 ↗
Tao Zhang · 1 shared paper, 2017 · strength 0.07
- Paper Astaxanthin inhibits gemcitabine-resistant human pancreatic cancer progression through EMT inhibition and gemcitabine r… DOI 10.3892/ol.2017.6836 ↗
Tao Yan · 1 shared paper, 2017 · strength 0.07
- Paper Astaxanthin inhibits gemcitabine-resistant human pancreatic cancer progression through EMT inhibition and gemcitabine r… DOI 10.3892/ol.2017.6836 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.